Results 151 to 160 of about 23,433 (212)

Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin B. [PDF]

Antimicrob Agents Chemother
Gebremariam T, Alkhazraji S, Gu Y, Najvar LK, Borroto-Esoda K, Patterson TF, Filler SG, Wiederhold NP, Ibrahim AS.   +8 more
europepmc   +1 more source

Comparative pharmacodynamics and dose optimization of liposomal amphotericin B against Candida species in an in vitro pharmacokinetic/pharmacodynamic model. [PDF]

Antimicrob Agents Chemother
Beredaki M-I, Arendrup MC, Pournaras S, Meletiadis J.   +3 more
europepmc   +1 more source

Intra-amniotic Candida albicans Infection Treated With Liposomal Amphotericin B With a Successful Neonatal Outcome. [PDF]

Open Forum Infect Dis
Gutiérrez NU, Vergara López MJ, Bustos CÁ, Vidal CC, Carvajal JA, Severino N, Giordano A, Baquedano SU, Feuerhake T, Rabagliati R, Balcells ME.   +10 more
europepmc   +1 more source

Infectious Diseases Physician Management of Cryptococcal Meningitis in North America-Is Single High-Dose Liposomal Amphotericin B Being Used? [PDF]

Open Forum Infect Dis
Bahr NC, Beekmann SE, Polgreen PM, Walker JB, Spec A, Boulware DR, Baddley JW.   +6 more
europepmc   +1 more source

Once-Weekly Liposomal Amphotericin B Use for Maintenance and Consolidation Phase Treatment of Cryptococcal Meningitis in Patients With AIDS. [PDF]

Cureus
Belinschi V, Iheagwara C, Muhanna A.
europepmc   +1 more source

A Real-World Data Observational Analysis of the Impact of Liposomal Amphotericin B on Renal Function Using Machine Learning in Critically Ill Patients. [PDF]

Antibiotics (Basel)
Sacanella I, Esteve-Pitarch E, Guevara-Chaux J, Berrueta J, García-Martínez A, Gómez J, Casarino C, Alés F, Canadell L, Martín-Loeches I, Grau S, Candel FJ, Bodí M, Rodríguez A.   +13 more
europepmc   +1 more source

Use of nebulized liposomal amphotericin B and posaconazole as antifungal prophylaxis in patients with severe SARS-CoV2 infection in intensive care unit. [PDF]

Infection
Fumarola B, Signorini L, Lorenzotti S, Lanza P, Saccani B, Van Hauwermeiren E, Mulè A, Piva S, Rota M, Zuccalà F, Rasulo FA, Filippini M, Bertazzoli A, Del Fabro G, Matteelli A.   +14 more
europepmc   +1 more source

Defining Optimal Doses of Liposomal Amphotericin B Against Candida auris: Data From an In Vitro Pharmacokinetic/Pharmacodynamic Model. [PDF]

J Infect Dis
Beredaki MI, Sanidopoulos I, Pournaras S, Meletiadis J.   +3 more
europepmc   +1 more source

Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report. [PDF]

Case Rep Ophthalmol
Zhou Y.
europepmc   +1 more source